MRO vs NVAX
MRO (MRO) versus Novavax Inc (NVAX) — a side-by-side from cached financials, not a winner call.
MRO (MRO) common stock.
Novavax Inc (NVAX) is a biotechnology company listed on US.
MRO does not have a complete income-statement cache yet.
Latest reported NVAX revenue for 2026-06-30 was $196.2M. Net income was -$62.9M. Revenue was up 40.6% from 2026-03-31 to 2026-06-30. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Not investment advice. Open the MRO and NVAX stock pages for the full models.
Not investment advice.